Batch of DPT vaccines in China found substandard

Image
Press Trust of India Beijing
Last Updated : Aug 11 2018 | 5:10 PM IST

Investigation by Chinese officials into recent vaccine scandal revealed that a batch of DPT vaccines was substandard.

DPT refers to a combination of vaccines for three infectious diseases -- diphtheria, pertussis and tetanus -- which are given to children.

China also exports DPT vaccines.

The batch of DPT vaccines, produced in July 2016 by Wuhan Institute of Biological Products Co Ltd, was proved substandard due to a short-term equipment failure, which resulted in improper distribution of active constituent in the vaccines, state-run Xinhua news agency quoted the findings of an investigation by officials into the recent vaccine scandal.

The official findings showed the company failed to take into account the malfunction and make targeted tests on the quality of its products during internal inspections.

The scare over the faulty scandal raised serious concerns in China.

Subsequent reports of faulty rabies vaccines have also created panic among public.

Authorities have launched a nationwide campaign to provide medical consultation and free inoculation of rabies vaccines.

Rabies vaccines made by the Changchun Changsheng Life Sciences Company, the second largest in China, found to have violated national standards including usage of expired fluids and falsified production dates.

The vaccines were also widely exported including to India.

The Drug Controller General of India, early this month, ordered an immediate withdrawal of rabies vaccines from the market and have also banned its imports from a Chinese manufacturer that allegedly fabricated records.

The defective DPT vaccines were not chosen in the random test of the National Institutes for Food and Drug Control (NIFDC) before being permitted to enter the market.

The NIFDC found in later tests last year that the effectiveness of the vaccine against pertussis did not meet national standards, the report said.

The results of the findings of a probe into a previous investigation of substandard DPT vaccines produced by Wuhan Institute of Biological Products Co. Ltd was released yesterday.

"The SDA (State Drug Administration) and related government agencies will demand the rectification of the wrongdoings, hold accountable involved company and supervisory departments, conduct re-vaccination for children affected, and release results to the public in a timely manner," the inspectors said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 11 2018 | 5:10 PM IST

Next Story